Golpayegani Mehdi, Edalatfar Maryam, Ahmadi Ayat, Sadeghi-Naini Mohsen, Salari Farhad, Hanaei Sara, Shokraneh Farhad, Ghodsi Zahra, Vaccaro Alex R, Rahimi-Movaghar Vafa
Sina Trauma and Surgery Research Center, 48439Tehran University of Medical Sciences, Tehran, Iran.
Knowledge Utilization Research Center, 48439Tehran University of Medical Sciences, Tehran, Iran.
Global Spine J. 2023 Jan;13(1):227-241. doi: 10.1177/21925682221094766. Epub 2022 Apr 29.
Systematic review: Considering the infiltrative nature of intramedullary astrocytoma, the goal of surgery is to have a better patient related outcome.
To compare the overall survival (OS) and neurologic outcomes of complete vs incomplete surgical resection for patients with intramedullary astrocytoma.
A comprehensive search of MEDLINE, CENTRAL and EMBASE was conducted by two independent reviewers. Individual patient data (IPD) analysis and multivariate Cox Proportional Hazard Model was developed to measure the effect of surgical strategies on OS, post-operative neurological improvement (PNI), and neurological improvement in the last follow up (FNI).
We included 1079 patients from 35 studies. Individual patient data of 228 patients (13 articles) was incorporated into the integrative IPD analysis. Kaplan-Meier survival analysis showed complete resection (CR) significantly improved OS in comparison with the incomplete resection (IR) (log-rank test, = .004). In the multivariate IPD analysis, three prognostic factors had significant effect on the OS: (1) Extent of Resection, (2) pathology grade, and (3) adjuvant therapy. We observed an upward trend in the popularity of chemotherapy, but CR, IR, and radiotherapy had relatively stable trends during three decades.
Our study shows that CR can improve OS when compared to IR. Patients with spinal cord astrocytoma undergoing CR had similar PNI and FNI compared to IR. Therefore, CR should be the primary goal of surgery, but intraoperative decisions on the extent of resection should be relied on to prevent neurologic adverse events. Due to significant effect of adjuvant therapy on OS, PNI and FNI, it could be considered as the routine treatment strategy for spinal cord astrocytoma.
系统评价:考虑到髓内星形细胞瘤的浸润性,手术的目标是获得更好的患者相关结局。
比较髓内星形细胞瘤患者完全手术切除与不完全手术切除的总生存期(OS)和神经学结局。
由两名独立的审阅者对MEDLINE、CENTRAL和EMBASE进行全面检索。开展个体患者数据(IPD)分析并建立多变量Cox比例风险模型,以衡量手术策略对OS、术后神经功能改善(PNI)和末次随访时神经功能改善(FNI)的影响。
我们纳入了35项研究中的1079例患者。将228例患者(13篇文章)的个体患者数据纳入综合IPD分析。Kaplan-Meier生存分析显示,与不完全切除(IR)相比,完全切除(CR)显著改善了OS(对数秩检验,P = 0.004)。在多变量IPD分析中,三个预后因素对OS有显著影响:(1)切除范围,(2)病理分级,(3)辅助治疗。我们观察到化疗的应用有上升趋势,但在三十年中CR、IR和放疗的趋势相对稳定。
我们的研究表明,与IR相比,CR可改善OS。接受CR的脊髓星形细胞瘤患者与接受IR的患者相比,PNI和FNI相似。因此,CR应是手术的主要目标,但应依靠术中关于切除范围的决策来预防神经不良事件。由于辅助治疗对OS、PNI和FNI有显著影响,可将其视为脊髓星形细胞瘤的常规治疗策略。